Trials / Enrolling By Invitation
Enrolling By InvitationNCT07057323
Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure
Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure With A Preserved Ejection Fraction Associated With Coronary Microvascular Dysfunction
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, specifically invasive measurement of PAWP during standardized exercise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Coronary Sinus Reducer | Subjects will have the Coronary Sinus Reducer implanted in their coronary sinus during a right heart catheterization procedure. |
Timeline
- Start date
- 2025-10-16
- Primary completion
- 2027-08-01
- Completion
- 2027-08-01
- First posted
- 2025-07-09
- Last updated
- 2026-03-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07057323. Inclusion in this directory is not an endorsement.